跳至主要内容
临床试验/JPRN-UMIN000010595
JPRN-UMIN000010595已完成未知

Comparison of clinical efficacy between peramivir and oseltamivir for the treatment of influenza in high-risk patients - A comparative study of peramivir and oseltamivir in high-risk patients

Hamamatsu University School of Medicine0 个研究点目标入组 60 人开始时间: 2013年4月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (i) Chronic respiratory failure requiring artificial ventilation (ii) Diabetes with an HbA1c value of >=10% (iii) Organ transplant or hematopoietic stem cell transplant within the previous 12 months (iv) Requirement for dialysis or presence of nephropathy (estimated creatinine clearance, <50 ml/min) (v) Presence of a complicating infection judged to require treatment by systemic administration of an antimicrobial agent (vi) Contraindication of peramivir and oseltamivir (vii) Pregnant women

研究者

相似试验

招募中
Unknown
The therapeutic effect of verapamil and triamcinolone along with macroneedling in the treatment of Peyronie's plaquePeyronie's plaque.N48.6Peyronie's disease
IRCT20230408057854N1Shahid Beheshti University of Medical Sciences64
已完成
不适用
The virology and clinical effects of peramivir on influenza virus infections in high-risk patients or patients with severe symptoms:an open-label, non-randomized, multi-centre study.Influenza virus infections.
JPRN-UMIN000007320Center for Advanced Medical Innovation Kyushu University20
招募中
1 期
Comparison of clinical effectiveness between average volume assured pressure support (AVAPS) with BiPAP S/T in chronic obstructive pulmonary disease with acute exacerbation: a randomized clinical trialAcute exacerbation of chronic obstructive pulmonary disease (AECOPD)AECOPDChronic obstructive pulmonary diseaseExacerbationNone invasive ventilationNIVNone invasive positive pressure ventilationNIPPVBiPAP S/TAverage Volume Assured Pressure SupportAV
TCTR20180903004Siriraj Hospital24
招募中
3 期
Efficacy of Remdesivir in Comparison with Interferon Beta-1 a and Remdesivir in the Treatment of Covid 19
IRCT20200721048159N4Vice Chancellor for Research and Technology of Lorestan University of Medical Sciences100
未知
不适用
The efficacy of paritaprevir and ombitasvir with a booster dose of ritonavir in genotype 1 HCV patients with hemodialysishemodialysis patients chronically infected with genotype 1 hepatitis C virus
JPRN-UMIN000022563Mitsui Memorial Hospital30